 | • レポートコード：GIR-107A11941 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、標的タンパク質分解のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。標的タンパク質分解の種類別市場規模（経口、静脈内、その他）、用途別市場規模（病院、研究所）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・標的タンパク質分解の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：5AM Venture Management LLC、AbbVie Inc、Almac Group、Amgen Inc.、Bayer AG、Biogen Inc.、C4 Therapeutics、Cosmo Bio USA、Covance Inc、Eli Lilly and Company、Gilead Sciences, Inc、GlaxoSmithKline plc、Merck KGaA、Mission Therapeutics、Novartis AG、Pfizer Inc、Promega ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口、静脈内、その他 ・用途別分析2016年-2026年：病院、研究所 ・標的タンパク質分解の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・標的タンパク質分解のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・標的タンパク質分解のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・標的タンパク質分解の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・標的タンパク質分解の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Targeted Protein Degradation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Targeted Protein Degradation size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Targeted Protein Degradation market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Targeted Protein Degradation market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Intravenous
Others
Market segment by Application, can be divided into
Hospital
Research Institute
Market segment by players, this report covers
5AM Venture Management LLC
AbbVie Inc
Almac Group
Amgen Inc.
Bayer AG
Biogen Inc.
C4 Therapeutics
Cosmo Bio USA
Covance Inc
Eli Lilly and Company
Gilead Sciences, Inc
GlaxoSmithKline plc
Merck KGaA
Mission Therapeutics
Novartis AG
Pfizer Inc
Promega
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Targeted Protein Degradation product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Targeted Protein Degradation, with revenue, gross margin and global market share of Targeted Protein Degradation from 2019 to 2021.
Chapter 3, the Targeted Protein Degradation competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Targeted Protein Degradation market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Targeted Protein Degradation research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Targeted Protein Degradation
1.2 Classification of Targeted Protein Degradation by Type
1.2.1 Overview: Global Targeted Protein Degradation Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Targeted Protein Degradation Revenue Market Share by Type in 2020
1.2.3 Oral
1.2.4 Intravenous
1.2.5 Others
1.3 Global Targeted Protein Degradation Market by Application
1.3.1 Overview: Global Targeted Protein Degradation Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Research Institute
1.4 Global Targeted Protein Degradation Market Size & Forecast
1.5 Global Targeted Protein Degradation Market Size and Forecast by Region
1.5.1 Global Targeted Protein Degradation Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Targeted Protein Degradation Market Size by Region, (2016-2021)
1.5.3 North America Targeted Protein Degradation Market Size and Prospect (2016-2026)
1.5.4 Europe Targeted Protein Degradation Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Targeted Protein Degradation Market Size and Prospect (2016-2026)
1.5.6 South America Targeted Protein Degradation Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Targeted Protein Degradation Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Targeted Protein Degradation Market Drivers
1.6.2 Targeted Protein Degradation Market Restraints
1.6.3 Targeted Protein Degradation Trends Analysis
2 Company Profiles
2.1 5AM Venture Management LLC
2.1.1 5AM Venture Management LLC Details
2.1.2 5AM Venture Management LLC Major Business
2.1.3 5AM Venture Management LLC Targeted Protein Degradation Product and Solutions
2.1.4 5AM Venture Management LLC Targeted Protein Degradation Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 5AM Venture Management LLC Recent Developments and Future Plans
2.2 AbbVie Inc
2.2.1 AbbVie Inc Details
2.2.2 AbbVie Inc Major Business
2.2.3 AbbVie Inc Targeted Protein Degradation Product and Solutions
2.2.4 AbbVie Inc Targeted Protein Degradation Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 AbbVie Inc Recent Developments and Future Plans
2.3 Almac Group
2.3.1 Almac Group Details
2.3.2 Almac Group Major Business
2.3.3 Almac Group Targeted Protein Degradation Product and Solutions
2.3.4 Almac Group Targeted Protein Degradation Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Almac Group Recent Developments and Future Plans
2.4 Amgen Inc.
2.4.1 Amgen Inc. Details
2.4.2 Amgen Inc. Major Business
2.4.3 Amgen Inc. Targeted Protein Degradation Product and Solutions
2.4.4 Amgen Inc. Targeted Protein Degradation Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Amgen Inc. Recent Developments and Future Plans
2.5 Bayer AG
2.5.1 Bayer AG Details
2.5.2 Bayer AG Major Business
2.5.3 Bayer AG Targeted Protein Degradation Product and Solutions
2.5.4 Bayer AG Targeted Protein Degradation Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Bayer AG Recent Developments and Future Plans
2.6 Biogen Inc.
2.6.1 Biogen Inc. Details
2.6.2 Biogen Inc. Major Business
2.6.3 Biogen Inc. Targeted Protein Degradation Product and Solutions
2.6.4 Biogen Inc. Targeted Protein Degradation Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Biogen Inc. Recent Developments and Future Plans
2.7 C4 Therapeutics
2.7.1 C4 Therapeutics Details
2.7.2 C4 Therapeutics Major Business
2.7.3 C4 Therapeutics Targeted Protein Degradation Product and Solutions
2.7.4 C4 Therapeutics Targeted Protein Degradation Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 C4 Therapeutics Recent Developments and Future Plans
2.8 Cosmo Bio USA
2.8.1 Cosmo Bio USA Details
2.8.2 Cosmo Bio USA Major Business
2.8.3 Cosmo Bio USA Targeted Protein Degradation Product and Solutions
2.8.4 Cosmo Bio USA Targeted Protein Degradation Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Cosmo Bio USA Recent Developments and Future Plans
2.9 Covance Inc
2.9.1 Covance Inc Details
2.9.2 Covance Inc Major Business
2.9.3 Covance Inc Targeted Protein Degradation Product and Solutions
2.9.4 Covance Inc Targeted Protein Degradation Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Covance Inc Recent Developments and Future Plans
2.10 Eli Lilly and Company
2.10.1 Eli Lilly and Company Details
2.10.2 Eli Lilly and Company Major Business
2.10.3 Eli Lilly and Company Targeted Protein Degradation Product and Solutions
2.10.4 Eli Lilly and Company Targeted Protein Degradation Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Eli Lilly and Company Recent Developments and Future Plans
2.11 Gilead Sciences, Inc
2.11.1 Gilead Sciences, Inc Details
2.11.2 Gilead Sciences, Inc Major Business
2.11.3 Gilead Sciences, Inc Targeted Protein Degradation Product and Solutions
2.11.4 Gilead Sciences, Inc Targeted Protein Degradation Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Gilead Sciences, Inc Recent Developments and Future Plans
2.12 GlaxoSmithKline plc
2.12.1 GlaxoSmithKline plc Details
2.12.2 GlaxoSmithKline plc Major Business
2.12.3 GlaxoSmithKline plc Targeted Protein Degradation Product and Solutions
2.12.4 GlaxoSmithKline plc Targeted Protein Degradation Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 GlaxoSmithKline plc Recent Developments and Future Plans
2.13 Merck KGaA
2.13.1 Merck KGaA Details
2.13.2 Merck KGaA Major Business
2.13.3 Merck KGaA Targeted Protein Degradation Product and Solutions
2.13.4 Merck KGaA Targeted Protein Degradation Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Merck KGaA Recent Developments and Future Plans
2.14 Mission Therapeutics
2.14.1 Mission Therapeutics Details
2.14.2 Mission Therapeutics Major Business
2.14.3 Mission Therapeutics Targeted Protein Degradation Product and Solutions
2.14.4 Mission Therapeutics Targeted Protein Degradation Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Mission Therapeutics Recent Developments and Future Plans
2.15 Novartis AG
2.15.1 Novartis AG Details
2.15.2 Novartis AG Major Business
2.15.3 Novartis AG Targeted Protein Degradation Product and Solutions
2.15.4 Novartis AG Targeted Protein Degradation Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Novartis AG Recent Developments and Future Plans
2.16 Pfizer Inc
2.16.1 Pfizer Inc Details
2.16.2 Pfizer Inc Major Business
2.16.3 Pfizer Inc Targeted Protein Degradation Product and Solutions
2.16.4 Pfizer Inc Targeted Protein Degradation Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Pfizer Inc Recent Developments and Future Plans
2.17 Promega
2.17.1 Promega Details
2.17.2 Promega Major Business
2.17.3 Promega Targeted Protein Degradation Product and Solutions
2.17.4 Promega Targeted Protein Degradation Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Promega Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Targeted Protein Degradation Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Targeted Protein Degradation Players Market Share
3.2.2 Top 10 Targeted Protein Degradation Players Market Share
3.2.3 Market Competition Trend
3.3 Targeted Protein Degradation Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Targeted Protein Degradation Revenue and Market Share by Type (2016-2021)
4.2 Global Targeted Protein Degradation Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Targeted Protein Degradation Revenue Market Share by Application (2016-2021)
5.2 Targeted Protein Degradation Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Targeted Protein Degradation Revenue by Type (2016-2026)
6.2 North America Targeted Protein Degradation Revenue by Application (2016-2026)
6.3 North America Targeted Protein Degradation Market Size by Country
6.3.1 North America Targeted Protein Degradation Revenue by Country (2016-2026)
6.3.2 United States Targeted Protein Degradation Market Size and Forecast (2016-2026)
6.3.3 Canada Targeted Protein Degradation Market Size and Forecast (2016-2026)
6.3.4 Mexico Targeted Protein Degradation Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Targeted Protein Degradation Revenue by Type (2016-2026)
7.2 Europe Targeted Protein Degradation Revenue by Application (2016-2026)
7.3 Europe Targeted Protein Degradation Market Size by Country
7.3.1 Europe Targeted Protein Degradation Revenue by Country (2016-2026)
7.3.2 Germany Targeted Protein Degradation Market Size and Forecast (2016-2026)
7.3.3 France Targeted Protein Degradation Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Targeted Protein Degradation Market Size and Forecast (2016-2026)
7.3.5 Russia Targeted Protein Degradation Market Size and Forecast (2016-2026)
7.3.6 Italy Targeted Protein Degradation Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Targeted Protein Degradation Revenue by Type (2016-2026)
8.2 Asia-Pacific Targeted Protein Degradation Revenue by Application (2016-2026)
8.3 Asia-Pacific Targeted Protein Degradation Market Size by Region
8.3.1 Asia-Pacific Targeted Protein Degradation Revenue by Region (2016-2026)
8.3.2 China Targeted Protein Degradation Market Size and Forecast (2016-2026)
8.3.3 Japan Targeted Protein Degradation Market Size and Forecast (2016-2026)
8.3.4 South Korea Targeted Protein Degradation Market Size and Forecast (2016-2026)
8.3.5 India Targeted Protein Degradation Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Targeted Protein Degradation Market Size and Forecast (2016-2026)
8.3.7 Australia Targeted Protein Degradation Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Targeted Protein Degradation Revenue by Type (2016-2026)
9.2 South America Targeted Protein Degradation Revenue by Application (2016-2026)
9.3 South America Targeted Protein Degradation Market Size by Country
9.3.1 South America Targeted Protein Degradation Revenue by Country (2016-2026)
9.3.2 Brazil Targeted Protein Degradation Market Size and Forecast (2016-2026)
9.3.3 Argentina Targeted Protein Degradation Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Targeted Protein Degradation Revenue by Type (2016-2026)
10.2 Middle East & Africa Targeted Protein Degradation Revenue by Application (2016-2026)
10.3 Middle East & Africa Targeted Protein Degradation Market Size by Country
10.3.1 Middle East & Africa Targeted Protein Degradation Revenue by Country (2016-2026)
10.3.2 Turkey Targeted Protein Degradation Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Targeted Protein Degradation Market Size and Forecast (2016-2026)
10.3.4 UAE Targeted Protein Degradation Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Targeted Protein Degradation Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Targeted Protein Degradation Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Targeted Protein Degradation Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Targeted Protein Degradation Revenue (USD Million) by Region (2016-2021)
Table 5. Global Targeted Protein Degradation Revenue Market Share by Region (2021-2026)
Table 6. 5AM Venture Management LLC Corporate Information, Head Office, and Major Competitors
Table 7. 5AM Venture Management LLC Major Business
Table 8. 5AM Venture Management LLC Targeted Protein Degradation Product and Solutions
Table 9. 5AM Venture Management LLC Targeted Protein Degradation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. AbbVie Inc Corporate Information, Head Office, and Major Competitors
Table 11. AbbVie Inc Major Business
Table 12. AbbVie Inc Targeted Protein Degradation Product and Solutions
Table 13. AbbVie Inc Targeted Protein Degradation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Almac Group Corporate Information, Head Office, and Major Competitors
Table 15. Almac Group Major Business
Table 16. Almac Group Targeted Protein Degradation Product and Solutions
Table 17. Almac Group Targeted Protein Degradation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Amgen Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Amgen Inc. Major Business
Table 20. Amgen Inc. Targeted Protein Degradation Product and Solutions
Table 21. Amgen Inc. Targeted Protein Degradation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Bayer AG Corporate Information, Head Office, and Major Competitors
Table 23. Bayer AG Major Business
Table 24. Bayer AG Targeted Protein Degradation Product and Solutions
Table 25. Bayer AG Targeted Protein Degradation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Biogen Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Biogen Inc. Major Business
Table 28. Biogen Inc. Targeted Protein Degradation Product and Solutions
Table 29. Biogen Inc. Targeted Protein Degradation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. C4 Therapeutics Corporate Information, Head Office, and Major Competitors
Table 31. C4 Therapeutics Major Business
Table 32. C4 Therapeutics Targeted Protein Degradation Product and Solutions
Table 33. C4 Therapeutics Targeted Protein Degradation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Cosmo Bio USA Corporate Information, Head Office, and Major Competitors
Table 35. Cosmo Bio USA Major Business
Table 36. Cosmo Bio USA Targeted Protein Degradation Product and Solutions
Table 37. Cosmo Bio USA Targeted Protein Degradation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Covance Inc Corporate Information, Head Office, and Major Competitors
Table 39. Covance Inc Major Business
Table 40. Covance Inc Targeted Protein Degradation Product and Solutions
Table 41. Covance Inc Targeted Protein Degradation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors
Table 43. Eli Lilly and Company Major Business
Table 44. Eli Lilly and Company Targeted Protein Degradation Product and Solutions
Table 45. Eli Lilly and Company Targeted Protein Degradation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Gilead Sciences, Inc Corporate Information, Head Office, and Major Competitors
Table 47. Gilead Sciences, Inc Major Business
Table 48. Gilead Sciences, Inc Targeted Protein Degradation Product and Solutions
Table 49. Gilead Sciences, Inc Targeted Protein Degradation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. GlaxoSmithKline plc Corporate Information, Head Office, and Major Competitors
Table 51. GlaxoSmithKline plc Major Business
Table 52. GlaxoSmithKline plc Targeted Protein Degradation Product and Solutions
Table 53. GlaxoSmithKline plc Targeted Protein Degradation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Merck KGaA Corporate Information, Head Office, and Major Competitors
Table 55. Merck KGaA Major Business
Table 56. Merck KGaA Targeted Protein Degradation Product and Solutions
Table 57. Merck KGaA Targeted Protein Degradation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Mission Therapeutics Corporate Information, Head Office, and Major Competitors
Table 59. Mission Therapeutics Major Business
Table 60. Mission Therapeutics Targeted Protein Degradation Product and Solutions
Table 61. Mission Therapeutics Targeted Protein Degradation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Novartis AG Corporate Information, Head Office, and Major Competitors
Table 63. Novartis AG Major Business
Table 64. Novartis AG Targeted Protein Degradation Product and Solutions
Table 65. Novartis AG Targeted Protein Degradation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Pfizer Inc Corporate Information, Head Office, and Major Competitors
Table 67. Pfizer Inc Major Business
Table 68. Pfizer Inc Targeted Protein Degradation Product and Solutions
Table 69. Pfizer Inc Targeted Protein Degradation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Promega Corporate Information, Head Office, and Major Competitors
Table 71. Promega Major Business
Table 72. Promega Targeted Protein Degradation Product and Solutions
Table 73. Promega Targeted Protein Degradation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Global Targeted Protein Degradation Revenue (USD Million) by Players (2019-2021)
Table 75. Global Targeted Protein Degradation Revenue Share by Players (2019-2021)
Table 76. Breakdown of Targeted Protein Degradation by Company Type (Tier 1, Tier 2 and Tier 3)
Table 77. Targeted Protein Degradation Players Head Office, Products and Services Provided
Table 78. Targeted Protein Degradation Mergers & Acquisitions in the Past Five Years
Table 79. Targeted Protein Degradation New Entrants and Expansion Plans
Table 80. Global Targeted Protein Degradation Revenue (USD Million) by Type (2016-2021)
Table 81. Global Targeted Protein Degradation Revenue Share by Type (2016-2021)
Table 82. Global Targeted Protein Degradation Revenue Forecast by Type (2021-2026)
Table 83. Global Targeted Protein Degradation Revenue by Application (2016-2021)
Table 84. Global Targeted Protein Degradation Revenue Forecast by Application (2021-2026)
Table 85. North America Targeted Protein Degradation Revenue by Type (2016-2021) & (USD Million)
Table 86. North America Targeted Protein Degradation Revenue by Type (2021-2026) & (USD Million)
Table 87. North America Targeted Protein Degradation Revenue by Application (2016-2021) & (USD Million)
Table 88. North America Targeted Protein Degradation Revenue by Application (2021-2026) & (USD Million)
Table 89. North America Targeted Protein Degradation Revenue by Country (2016-2021) & (USD Million)
Table 90. North America Targeted Protein Degradation Revenue by Country (2021-2026) & (USD Million)
Table 91. Europe Targeted Protein Degradation Revenue by Type (2016-2021) & (USD Million)
Table 92. Europe Targeted Protein Degradation Revenue by Type (2021-2026) & (USD Million)
Table 93. Europe Targeted Protein Degradation Revenue by Application (2016-2021) & (USD Million)
Table 94. Europe Targeted Protein Degradation Revenue by Application (2021-2026) & (USD Million)
Table 95. Europe Targeted Protein Degradation Revenue by Country (2016-2021) & (USD Million)
Table 96. Europe Targeted Protein Degradation Revenue by Country (2021-2026) & (USD Million)
Table 97. Asia-Pacific Targeted Protein Degradation Revenue by Type (2016-2021) & (USD Million)
Table 98. Asia-Pacific Targeted Protein Degradation Revenue by Type (2021-2026) & (USD Million)
Table 99. Asia-Pacific Targeted Protein Degradation Revenue by Application (2016-2021) & (USD Million)
Table 100. Asia-Pacific Targeted Protein Degradation Revenue by Application (2021-2026) & (USD Million)
Table 101. Asia-Pacific Targeted Protein Degradation Revenue by Region (2016-2021) & (USD Million)
Table 102. Asia-Pacific Targeted Protein Degradation Revenue by Region (2021-2026) & (USD Million)
Table 103. South America Targeted Protein Degradation Revenue by Type (2016-2021) & (USD Million)
Table 104. South America Targeted Protein Degradation Revenue by Type (2021-2026) & (USD Million)
Table 105. South America Targeted Protein Degradation Revenue by Application (2016-2021) & (USD Million)
Table 106. South America Targeted Protein Degradation Revenue by Application (2021-2026) & (USD Million)
Table 107. South America Targeted Protein Degradation Revenue by Country (2016-2021) & (USD Million)
Table 108. South America Targeted Protein Degradation Revenue by Country (2021-2026) & (USD Million)
Table 109. Middle East & Africa Targeted Protein Degradation Revenue by Type (2016-2021) & (USD Million)
Table 110. Middle East & Africa Targeted Protein Degradation Revenue by Type (2021-2026) & (USD Million)
Table 111. Middle East & Africa Targeted Protein Degradation Revenue by Application (2016-2021) & (USD Million)
Table 112. Middle East & Africa Targeted Protein Degradation Revenue by Application (2021-2026) & (USD Million)
Table 113. Middle East & Africa Targeted Protein Degradation Revenue by Country (2016-2021) & (USD Million)
Table 114. Middle East & Africa Targeted Protein Degradation Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Targeted Protein Degradation Picture
Figure 2. Global Targeted Protein Degradation Revenue Market Share by Type in 2020
Figure 3. Oral
Figure 4. Intravenous
Figure 5. Others
Figure 6. Targeted Protein Degradation Revenue Market Share by Application in 2020
Figure 7. Hospital Picture
Figure 8. Research Institute Picture
Figure 9. Global Targeted Protein Degradation Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Targeted Protein Degradation Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Targeted Protein Degradation Revenue Market Share by Region (2016-2026)
Figure 12. Global Targeted Protein Degradation Revenue Market Share by Region in 2020
Figure 13. North America Targeted Protein Degradation Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Targeted Protein Degradation Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Targeted Protein Degradation Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Targeted Protein Degradation Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Targeted Protein Degradation Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Targeted Protein Degradation Market Drivers
Figure 19. Targeted Protein Degradation Market Restraints
Figure 20. Targeted Protein Degradation Market Trends
Figure 21. 5AM Venture Management LLC Recent Developments and Future Plans
Figure 22. AbbVie Inc Recent Developments and Future Plans
Figure 23. Almac Group Recent Developments and Future Plans
Figure 24. Amgen Inc. Recent Developments and Future Plans
Figure 25. Bayer AG Recent Developments and Future Plans
Figure 26. Biogen Inc. Recent Developments and Future Plans
Figure 27. C4 Therapeutics Recent Developments and Future Plans
Figure 28. Cosmo Bio USA Recent Developments and Future Plans
Figure 29. Covance Inc Recent Developments and Future Plans
Figure 30. Eli Lilly and Company Recent Developments and Future Plans
Figure 31. Gilead Sciences, Inc Recent Developments and Future Plans
Figure 32. GlaxoSmithKline plc Recent Developments and Future Plans
Figure 33. Merck KGaA Recent Developments and Future Plans
Figure 34. Mission Therapeutics Recent Developments and Future Plans
Figure 35. Novartis AG Recent Developments and Future Plans
Figure 36. Pfizer Inc Recent Developments and Future Plans
Figure 37. Promega Recent Developments and Future Plans
Figure 38. Global Targeted Protein Degradation Revenue Share by Players in 2020
Figure 39. Targeted Protein Degradation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 40. Global Top 3 Players Targeted Protein Degradation Revenue Market Share in 2020
Figure 41. Global Top 10 Players Targeted Protein Degradation Revenue Market Share in 2020
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 43. Global Targeted Protein Degradation Revenue Share by Type in 2020
Figure 44. Global Targeted Protein Degradation Market Share Forecast by Type (2021-2026)
Figure 45. Global Targeted Protein Degradation Revenue Share by Application in 2020
Figure 46. Global Targeted Protein Degradation Market Share Forecast by Application (2021-2026)
Figure 47. North America Targeted Protein Degradation Sales Market Share by Type (2016-2026)
Figure 48. North America Targeted Protein Degradation Sales Market Share by Application (2016-2026)
Figure 49. North America Targeted Protein Degradation Revenue Market Share by Country (2016-2026)
Figure 50. United States Targeted Protein Degradation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Canada Targeted Protein Degradation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Mexico Targeted Protein Degradation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Europe Targeted Protein Degradation Sales Market Share by Type (2016-2026)
Figure 54. Europe Targeted Protein Degradation Sales Market Share by Application (2016-2026)
Figure 55. Europe Targeted Protein Degradation Revenue Market Share by Country (2016-2026)
Figure 56. Germany Targeted Protein Degradation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. France Targeted Protein Degradation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. United Kingdom Targeted Protein Degradation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Russia Targeted Protein Degradation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Italy Targeted Protein Degradation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Asia-Pacific Targeted Protein Degradation Sales Market Share by Type (2016-2026)
Figure 62. Asia-Pacific Targeted Protein Degradation Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Targeted Protein Degradation Revenue Market Share by Region (2016-2026)
Figure 64. China Targeted Protein Degradation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Japan Targeted Protein Degradation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South Korea Targeted Protein Degradation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. India Targeted Protein Degradation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Southeast Asia Targeted Protein Degradation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Australia Targeted Protein Degradation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South America Targeted Protein Degradation Sales Market Share by Type (2016-2026)
Figure 71. South America Targeted Protein Degradation Sales Market Share by Application (2016-2026)
Figure 72. South America Targeted Protein Degradation Revenue Market Share by Country (2016-2026)
Figure 73. Brazil Targeted Protein Degradation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Argentina Targeted Protein Degradation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Middle East and Africa Targeted Protein Degradation Sales Market Share by Type (2016-2026)
Figure 76. Middle East and Africa Targeted Protein Degradation Sales Market Share by Application (2016-2026)
Figure 77. Middle East and Africa Targeted Protein Degradation Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Targeted Protein Degradation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Targeted Protein Degradation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. UAE Targeted Protein Degradation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界のNSCLC用標的薬物MEK阻害剤市場 2021：企業別、地域別、種類・用途別 The Targeted Drug MEK Inhibitors for NSCLC market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…- 世界のNSCLC用標的薬VEGFR2阻害剤市場 2021：企業別、地域別、種類・用途別 The Targeted Drug VEGFR2 Inhibitors for NSCLC market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 世界のNSCLC用標的薬BRAF阻害剤市場 2021：企業別、地域別、種類・用途別 The Targeted Drug BRAF Inhibitors for NSCLC market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 世界の乳がん用HER-2標的薬市場 2021：企業別、地域別、種類・用途別 The HER-2 Targeted Drugs for Breast Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- 世界のNSCLC用標的薬ALK阻害剤市場 2021：企業別、地域別、種類・用途別 The Targeted Drug ALK Inhibitors for NSCLC market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…